TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/20/2022
Back to search
Official data from USPTO
PROTEONIC
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PROTEONIC
ST13
US500000088735286Class
1, 5, 40, 42
Filing
88735286
Registration
6464397
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
07/20/2022
Trademark type
Word
Nice classes
1, 5, 40, 42
Filing date
12/20/2019
Registration date
08/24/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/24/2021
Last transaction
04/29/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
First use anywhere
08/31/2004
First use in commerce
04/12/2006
Drawing code
4
Owner type
99
Owner location
Leiden, NL
Examiner
KEAN, AMY C
Law office
N30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
ProteoNic Biotechnology IP B.V.
Representatives
Julianne Abelman Womble Bond Dickinson (US) LLP
Technical classification
Nice Classes
Class 1Class 5Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicalbiochemical and biological products for use in industry and science for use in production of polypeptides and monoclonal antibodies for in vitro scientific or research use; Reagents for scientific and research use
Class 5
Biological products for medical use in recombinant DNA technologyDNA products allowing recombinant production of polypeptides and monoclonal antibodies; Reagents for medical use
Class 40
Custom manufacture of biopharmaceuticals; Custom manufacture of genetically modified cells and vectors
Class 42
Design of biopharmaceuticals; Design of genetically modified cells and vectors; Sciencetechnologyresearch and design servicesmicro- and molecular biologypharmaceuticals; Industrial analysis and research services in the nature of biotechnology product and production research in the field of biological pharmaceuticals; Consultancy in the field of recombinant DNA technology; Provision of information relating to industrial engineeringknowhow on DNA sequences relating to improving protein production
Publications
History of USPTO decisions and trademark events.
32 publications found
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
07/20/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/20/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/20/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
08/24/2021
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
07/20/2021
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
07/17/2021
SUPC
STATEMENT OF USE PROCESSING COMPLETE
06/10/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
06/09/2021
IUAF
USE AMENDMENT FILED
05/27/2021
EISU
TEAS STATEMENT OF USE RECEIVED
05/27/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/17/2021
EX1G
SOU EXTENSION 1 GRANTED
03/15/2021
EXT1
SOU EXTENSION 1 FILED
03/15/2021
EEXT
SOU TEAS EXTENSION RECEIVED
03/15/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
09/15/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/21/2020
PUBO
PUBLISHED FOR OPPOSITION
07/21/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/01/2020
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
06/16/2020
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
06/12/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/08/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/08/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/08/2020
ALIE
ASSIGNED TO LIE
05/07/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/04/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/23/2020
GNRT
NON-FINAL ACTION E-MAILED
03/23/2020
CNRT
NON-FINAL ACTION WRITTEN
03/23/2020
DOCK
ASSIGNED TO EXAMINER
03/18/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/30/2019
NWAP
NEW APPLICATION ENTERED
12/24/2019
Continuous trademark protection
Get notified about every new filing that threatens PROTEONIC or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.